Cargando…
Development and Validation of a Multiplex Non-HLA Antibody Assay for the Screening of Kidney Transplant Recipients
The best treatment for patients with end-stage renal disease is kidney transplantation. Although graft survival rates have improved in the last decades, patients still may lose their grafts partly due to the detrimental effects of donor-specific antibodies (DSA) against human leukocyte antigens (HLA...
Ejemplares similares
-
Antibodies against ARHGDIB are associated with long‐term kidney graft loss
por: Kamburova, Elena G., et al.
Publicado: (2019) -
Toward a Sensible Single-antigen Bead Cutoff Based on Kidney Graft Survival
por: Wisse, Bram W., et al.
Publicado: (2019) -
Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients
por: Heidt, Sebastiaan, et al.
Publicado: (2019) -
T-Cell Epitopes Shared Between Immunizing HLA and Donor HLA Associate With Graft Failure After Kidney Transplantation
por: Peereboom, Emma T. M., et al.
Publicado: (2021) -
PIRCHE-II Is Related to Graft Failure after Kidney Transplantation
por: Geneugelijk, Kirsten, et al.
Publicado: (2018)